Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 2/20 | 0.58 |
| ▸ | F2 | P00734 | 1/20 | 0.58 |
| ▸ | HTR2A | P28223 | 1/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.46 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.44 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | TACR1 | P25103 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6745618 | 0.81 | DPP4 (0.58) | DPP4F2HTR2ATAAR1ADRA2A | |
| SCHEMBL27989314 | 0.81 | DPP4 (0.58) | DPP4F2HTR2ATAAR1ADRA2A | |
| Hydrochloric Acid SCHEMBL1434607 | 0.80 | DPP4 (0.50) | DPP4F2HTR2ATAAR1ADRA2A | |
| SCHEMBL448348 | 0.79 | DPP4 (0.53) | DPP4F2HTR2ATAAR1LMNA | |
| Hydrochloric Acid SCHEMBL28019527 | 0.79 | DPP4 (0.55) | DPP4F2HTR2ATAAR1ADRA2A | |
| SCHEMBL1168297 | 0.79 | DPP4 (0.72) | DPP4F2HTR2ATAAR1ADRA2A | |
| SCHEMBL1143444 | 0.79 | DPP4 (0.72) | DPP4F2HTR2ATAAR1ADRA2A | |
| SCHEMBL1143202 | 0.79 | DPP4 (0.72) | DPP4F2HTR2ATAAR1ADRA2A | |
| SCHEMBL1168170 | 0.77 | ADRA2A (0.58) | DPP4F2TAAR1ADRA2AADRA2C | |
| SCHEMBL4451068 | 0.77 | DPP4 (0.52) | DPP4F2ADRA2AADRA2CLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105505136-B | A kind of standby UV coating of polyurethane based on cyclic carbonate ester synthesis | 滁州金桥德克新材料有限公司 | 2018-04-17 | — | — | CN | claimed |
| EP-2616169-A2 | CHROMATOGRAPHY MEMBRANES FOR THE PURIFICATION OF CHIRAL COMPOUNDS | Natrix Separations Inc. (CA) | 2013-07-24 | — | — | EP | claimed |
| WO-2012037101-A2 | CHROMATOGRAPHY MEMBRANES FOR THE PURIFICATION OF CHIRAL COMPOUNDS | NATRIX SEPARATIONS INC. (CA) | 2012-03-22 | — | — | WO | claimed |
| US-20250340568-A1 | SOLID FORMS OF A MACROCYCLIC COMPOUNDS AS CFTR MODULATORS AND THEIR PREPARATION | VERTEX PHARMA (US) | 2025-11-06 | — | — | US | disclosed |
| US-20250320226-A1 | METHODS OF PREPARING AND CRYSTALLINE FORMS OF (6A,12A)-17-AMINO-12-METHYL-6,15-BIS(TRIFLUOROMETHYL)-13,19-DIOXA-3,4,18-TRIAZATRICYCLO[12.3.1.12,5]NONADECA-1(18),2,4,14,16-PENTAEN-6-OL | VERTEX PHARMA (US) | 2025-10-16 | — | — | US | disclosed |
| CN-115819794-B | Modified epoxy resin, preparation method thereof and UV epoxy resin pouring sealant | 长春永固科技有限公司 | 2024-11-22 | — | — | CN | disclosed |
| CN-115401849-A | Resin composition mixing device for preparing polishing pad and polishing pad preparation method | SKC索密思株式会社 | 2022-11-29 | — | — | CN | disclosed |
| CN-115401603-A | Polishing pad adhesive film, polishing pad laminate comprising same, and method for polishing wafer | SKC索密思株式会社 | 2022-11-29 | — | — | CN | disclosed |
| CN-111378085-B | Composition for polishing pad, polishing pad and preparation method thereof | SKC索密思株式会社 | 2022-05-03 | — | — | CN | disclosed |
| CN-111378085-A | Composition for polishing pad, polishing pad and preparation method thereof | SKC株式会社 | 2020-07-07 | — | — | CN | disclosed |
| CN-111293327-A | Flexible sealing sheet, flexible sealing member, and flexible sealing structure | 律胜科技股份有限公司 | 2020-06-16 | — | — | CN | disclosed |
| EP-0104396-B1 | PROCESS FOR PREPARATION OF DIAMINES OR MIXTURES OF DIAMINES | BAYER AG (DE) | 1985-11-13 | — | — | EP | disclosed |
| EP-0158952-A2 | Triamines, a process for their preparation and their use as cross-linking agents or hardeners for plastic materials or precursors having epoxy- or isocyanate-groups | BAYER AG (DE) | 1985-10-23 | — | — | EP | disclosed |
| EP-0158953-A2 | Triamines, a process for their preparation and their use as cross-linking agents or hardeners for plastic materials or precursers having epoxy or isocyanate-groups | BAYER AG (DE) | 1985-10-23 | — | — | EP | disclosed |
| EP-0104396-A1 | Process for preparation of diamines or mixtures of diamines | BAYER AG (DE) | 1984-04-04 | — | — | EP | disclosed |
| EP-0104531-A1 | Cycloaliphatic diisocyanates, possibly in the form of a mixture of isomers, method for their preparation and their use as starting products in the preparation of synthetic products of the polyurethane type | BAYER AG (DE) | 1984-04-04 | — | — | EP | disclosed |
| EP-0046917-B1 | POLYISOCYANATE MIXTURES OF THE DIPHENYLMETHANE CLASS, AS WELL AS THEIR USE AS SYNTHESIS COMPONENTS IN THE MANUFACTURE OF POLYURETHANES BY THE ISOCYANATE-POLYADDITION PROCESS | BAYER AG (DE) | 1983-12-07 | — | — | EP | disclosed |
| EP-0024665-B1 | DIISOCYANATES OR MIXTURES OF DIISOCYANATES OF THE DIPHENYL-METHANE SERIES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS A SYNTHESIS COMPONENT TO PRODUCE POLYURETHANE PLASTICS ACCORDING TO THE ISOCYANATE-POLYADDITION PROCESS | BAYER AG (DE) | 1982-05-05 | — | — | EP | disclosed |
| EP-0046917-A1 | Polyisocyanate mixtures of the diphenylmethane class, as well as their use as synthesis components in the manufacture of polyurethanes by the isocyanate-polyaddition process | BAYER AG (DE) | 1982-03-10 | — | — | EP | disclosed |
| EP-0024665-A1 | Diisocyanates or mixtures of diisocyanates of the diphenyl-methane series, process for their preparation and their use as a synthesis component to produce polyurethane plastics according to the isocyanate-polyaddition process | BAYER AG (DE) | 1981-03-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250340568-A1 | SOLID FORMS OF A MACROCYCLIC COMPOUNDS AS CFTR MODULATORS AND THEIR PREPARATION | CFTR, SLC26A4, PKD1 | DPP4 1114/4885F2 1295/4885HTR2A 3653/4885 |
| US-20250320226-A1 | METHODS OF PREPARING AND CRYSTALLINE FORMS OF (6A,12A)-17-AMINO-12-METHYL-6,15-BIS(TRIFLUOROMETHYL)-13,19-DIOXA-3,4,18-TRIAZATRICYCLO[12.3.1.12,5]NONADECA-1(18),2,4,14,16-PENTAEN-6-OL | CFTR, PKD1, AQP1 | DPP4 1232/4885F2 382/4885HTR2A 1438/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.